Nov. 4, 2011
/PRNewswire/ -- A consortium comprised of funds advised by Apax Partners ("Apax"), together with controlled affiliates of Canada Pension Plan Investment Board ("CPPIB") and the Public Sector Pension Investment Board ("PSP Investments"), today announced the completion of its acquisition of Kinetic Concepts, Inc. (NYSE: KCI) for
per common share in cash. KCI shareholders approved the transaction at a special meeting held on 28th October.
KCI is a U.S.-based medical device company focused on the design, manufacture, marketing and service of therapies and products for the wound care, tissue regeneration and therapeutic support system markets. The transaction is valued at approximately
, including KCI's outstanding debt.
The consortium plans to work actively in partnership with the management of KCI to further invest in the global medical products sector to expand the company's core business, develop innovative products and extend into new geographies where significant opportunities exist.
Morgan Stanley & Co. LLC acted as financial advisor to the consortium. Debt financing was secured from Morgan Stanley & Co. LLC, BofA Merrill Lynch and Credit Suisse AG. Simpson Thacher & Bartlett LLP acted as legal advisor to the consortium. Kirkland & Ellis LLP acted as legal advisor on the financing to the consortium. Epstein Becker Green acted as healthcare regulatory counsel to the consortium. CPPIB was also separately advised by Torys LLP. PSP Investments was also separately advised by Weil, Gotshal & Manges LLP.
About Apax Partners
Apax Partners is one of the world's leading private equity investment groups. It operates across
the United States
and has more than 30 years of investing experience. Funds under the advice of Apax Partners total over
around the world. These Funds provide long-term equity financing to build and strengthen world-class companies. Apax Partners Funds invest in companies across its global sectors of Tech & Telecom, Retail & Consumer, Media, Healthcare and Financial & Business Services.
The Healthcare team at Apax has focused on the medical devices / wound care sub-sector for many years, having previously invested in Molnlycke Health Care Group (MHCG) in 2003. In the case of Molnlycke, the team identified a consolidation opportunity in the wound care space and combined three separate businesses to create a leading global medical products company.